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The MRC OX-44 leukocyte antigen is a glycoprotein ofM, 40-50 x 103 that is
of interest because it allows the identification of an intermediate cell type in rat
thymopoiesis that has the CD4-CD8+OX-44- phenotype (1, 2). Most CD4+CD8+
thymocytes are also OX-44-, whereas other leukocytes are virtually all OX-44+. In
the mature lymphocyte population, B cells express considerably more antigen than
T cells (1).
In other species, no equivalent to OX-44 was obvious, but the human CD37 an-
tigen showed some similarities to OX-44intissue distribution and mobility in SDS-
PAGE (3). The CD37 antigen was first defined as being abundantly expressed on
B lymphocytes, but the antigen is also seen at lower levels on T cells, some thymo-
cytes, neutrophils, monocytes, and macrophages (3, 4). The function of CD37 is
unknown, although it has been shown that a CD37 mAb can inhibit the activation
of B cells induced by CD20 antibodies plus B cell growth factor (5).
Structural studies were initiated on OX-44by proteinpurification and sequencing
and on CD37 bycDNA cloning via antigen expression. The results show that these
antigens are species homologues and the complete sequence of human CD37 is
reported.
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Materials and Methods
BriefDefinitive Report
Protein Purification, SDS-PAGE, and Western Blot Analysis.
￿
The ratOX-44 antigen was purified
from spleen cell membrane solubilized in deoxycholate by two rounds ofmAb affinity chro-
matography. Purified OX-44 antigenwas analyzedbySDS-PAGE followed by silver staining
or Western blotting and all techniques were essentially as described (6).
Protein Sequencing andAmino AcidAnalysis.
￿
Purified OX-44proteinwas reducedandalkylated
(7)and afteracetone precipitation was reconstituted in 20o7o TEAforloadingonto apolybrene-
treated, precycled glass fibre disc in an ABI 470A gas/liquid/solid-phase protein sequencer
(Applied Biosystems, Foster City, CA). Phenylthiohydantoin (PTH) amino acid derivatives
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were identified by HPLC. Amino acid analysis on performic acid oxidized OX-44 was per-
formed (8).
Preparation ofcDNA Library andRecovery of cDNA Clones by Panning.
￿
Poly(A)' RNA was pre-
pared from cells isolated by leukopheresis from a patient with chronic lymphocytic leukemia
and cDNA was prepared and used to construct an expression library (9).
Anti-CD37 mAbs were obtained from theInternational LeukocyteTyping Workshop (4).
Panning andscreeningcycles performed by spheroplast fusion were carried outas described (9).
DNASequencing RNA andDNA Blot Hybridization.
￿
Purified CD37.1 plasmid was digested
with restriction enzymesand fragmentswere subcloned into M13 mp8 andM13mpI9. Recom-
binant M13 clones were sequenced by the dideoxy method using the Sequenase reagent kit
(U. S. Biochemicals, Cleveland, OH) with the Sequenase enzyme (U. S. Biochemicals) or
T7 DNA polymerase (Pharmacia Fine Chemicals, Uppsala, Sweden). DNA sequences were
analyzed usingthecomputer programs ofStaden (10). Theentire cDNA insert wassequenced
in both directions and each nucleotide was determined an average of six times.
DNA and RNAextractions, blotting and hybridizationwere carriedout as described pre-
viously (9, 11).
Results and Discussion
The OX-44 antigen was purified by two rounds of immunoafftnity chromatog-
raphy and an aliquot of the eluted material was analyzed by SDS-PAGE. After the
first affinity step a broad band of material of M, 40 x 103 was seen with a number
ofminor contaminants (datanot shown). On repassagethrough the affinity column,
theheterogeneous material was again boundand eluted (Fig. 1 A). The OX-44 anti-
genic material was shown to coincide with the broad band by Western blotting (Fig.
1 B; note the gels in A and Bwere run with separate antigen preparations), in accord
with previous results obtained with radiolabeled OX-44 (1). The material was fur-
ther assessed by amino acid analysis (Fig. 1 C), which revealed unusuallyhigh levels
of Leu (13%) and Phe (7%), consistent with the presence of one predominant mo-
lecular species. Two separate preparations of reduced and alkylated OX-44 were se-
quenced, and in each case a single NH2-terminal sequence was obtained (Fig. 2 C),
with the exception of residue 1, which was not assigned due to the presence ofmul-
tiple PTH-amino acid derivatives. In a third sequencing run on a separate antigen
preparation, a major sequence identical to the previous two runs was obtained and
PTH-Gly was unambiguously identified at cycle 1. The NH2-terminal sequence of
OX-44 was notable for its high content of hydrophobic amino acid residues.
A CD37 clone was isolated using a COS cell expression system (9, 11) and the
complete nucleotide sequence of the cDNA insert is shown in Fig. 2 A. The insert
of 1124 by contained a single open reading frame of 732 by encoding a protein of
244 amino acids with a predicted molecular mass of 27,376 daltons (Fig. 2 B). The
insert size of the CD37 cDNA is consistent with the size of the CD37 mRNA (1 .2
kb) from various cell types of the B lymphoid and monocytic lineages (Fig. 1 D).
Southern blot analysis with DNA from various B cell lines and placenta digested
with Eco RI or Hind III showed a pattern consistent with that of a single copy gene
(data not shown).
A comparison of the NH2-terminal sequences of CD37 and OX-44 clearly shows
that the two proteins are homologous, with 14 identities and 4 conservative amino
acid substitutions over the first 29 residues (Fig. 2 C). At first inspection, the CD37
NH2-terminal sequence (residues 1-26) closely resembled aconventional leader se-
quence (Fig. 2 B). However, the matchwith theOX-44protein sequence which begins
only three residues after Met-1 of CD37 (Fig. 2 C) suggests that CD37 lacks a cleavedP)
FIGURE 1 .
￿
Protein andmRNA analysis . (A) 25 pmol (1 wg) twice affinity-purified OX-44 elec-
trophoresed on a 10% polyacrylamide gel in SDS under reducing conditions and silver stained .
Molecular mass markers (kD) are indicated . (B) Western blot oftwice affinity-purifiedOX-44 .
Purified OX-44 antigen was subjected to SDS-PAGE and transferred to nitrocellulose membrane .
The OX-44 antigen was detected using theOX-44 mAb and
125I-labeled, affinity-purified rabbit
anti-mouse IgG antibody . (C) Amino acid analysis (residues per 100amino acids) derived from
duplicate analyses of 10 Wg OX-44 after periodic acid oxidation and hydrolysis for 24 h at 110°C
with 5.7 N HCl and 0.01 M phenol . Loss of Ser and Thr were not corrected for and Trp was
not determined . Avalue forGly is not given because this amino acid was present at high levels .
Since glycine was used to neutralize the OX-44 preparation after high pH elution this presum-
ably represents glycine contamination remaining after dialysis. Theamino acid composition es-
timatedfrom the translated sequence ofthe humanCD37 cDNA (Fig . 2 B) is shown for compar-
ison . (D) RNAblot analysis of CD37 . RNA isolation, electrophoresis and blots were performed
as described (11) . RNA sources were as follows : (A) HL-60 ; (B) U937 ; (C) tonsillarB cells; (D)
HUT-102 ; (E) HPB-ALL ; (F) RPMI 8226 ; (G) LESS; (H) Raji; (1) Nalm 6 .
gtctcccccactgtcagcacctc[[ccgtgtggtgag[ggaccgc[taccccactaggtg 60
aa~[cagcccaggagagc[gcc[cagcccca[caagtacc[cctc[tcgttt[caac 120
ccg[cttcggcagcctgatcttctgcttcggcatctggatcotcatcgac 180
aagaccagc[[cg[gtcccttgtgggcc[gqcct[cqtgcctctqcagatc[ggtccaaa 240
gccccggccacctcaggaacac[caoeatgggcatcgce ottgggttgtgtmggcc 300
caaggagctcegctgcctectgggcctqta[tttgggatgetgetgcteetgtttgec 360
cagatcaccctgggaatcctcatccccac[cagcgggcccagctggagcqaagct[g 420
cgggacgCCg[agagaaaaccacccaaaagcacggcacCaaccwgaggagaccgcgg¢ 490
gaggagagc[gggacta[g[gcagttccagctgcgctgctgcggctggcactacccgcag 540
gactqg[[ccasgtcctcatcctgagaggtsacgggtcggaggcgcaccgcgtgccccgc 600
Ccctgccacaacttgtcggcgaccaacgaccccaoaatcctagataaggcgatcttgcac 660
cagctcagcaggct[ggacacctggcgcggtccagacacagtgcagaca[ctgcgctg[c 720
cctgcagagagccacatctaccgcqagqctgcgcgcaggqcctctagaagcggctgcata 790
c ca[t[cct Eadtgggcatttgcetgggegteggcttactegagctagggttca 840
cgacgc[c[cgata['E' gCgcagaaacctggaccacgtctacaaccggctcgctcgat 900
cOgtcaggccccgccctccccaaagtcccgccccgcccccgtcacgcgcgccgggcact 960
ctgctgcctqtaaatat[tgtttaatccccag[tcgcct99&9ccc[ccgecttcac 1020
attcccctggggacccacq[ggc[qcgcgcccc[gttgc[q[eaCCtetCCcacgggacc 1080
tggggcct[cgtccacagcctcc[gtCCcca'C[gtcggcctac
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FIGURE 2 .
￿
(A)The complete nucleotide sequence
ofthe CD37cDNA insert. The startcodon at po-
sition 64 and the stop codon at position 798 are
boxed . (B) The complete protein sequence of
CD37 . Postulated transmembrane sequences are
boxedand N-linked glycosylation sites are under-
lined. (C) NH2-terminal sequence homology be-
tween CD37 and OX-44 . Identical amino acid
residues areboxed. TheOX-44 sequence was de-
rived from three independent sequencing runs .
These sequence data have been submitted to the
EMBL/GenBank Data Libraries under accession
number X14046.1500
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leader sequence and is therefore orientated in the membrane such that the NH2
terminus is located inside the cell. Given that CD37 and OX-44 are species homo-
logues, the latter would also be expected to contain an uncleaved N142-terminal
signal sequence and have a Met at position 1 but this is not the case (Fig. 2 C).
It is possible that OX-44 has lost one or more NH2-terminal residues by proteol-
ysis during purification of the antigen from spleen extracts.
Anotablefeatureof the CD37 protein sequence is the high contentofhydrophobic
residues in the NH2-terminal half of the molecule (Fig. 3). It seems likely that this
part of theprotein will cross the membrane more than once andthreeputative trans-
membrane sequences have been assigned (Fig. 2 B). These are tentatively suggested
since the fairly uniform hydrophobicity makes precise demarcation difficult. The
positions of polar and charged amino acids may mark turns in the sequence that
are outside the lipid bilayer but this is unclear since polar residues are sometimes
found in putative transmembrane sequences of molecules that cross the membrane
a number of times (12) or those that form multimolecular complexes in the bilayer
(13). The significance of the two Glu residues assigned at positions 24 and 25 in
the OX-44 sequence is unclear, given their absence from equivalent positions in the
CD37 sequence. These residues may conflict with the transmembrane assignments
shown in Fig. 2 B and the confirmation of these Glu residues at the cDNA level
will be needed before any firm conclusions are drawn.
The COOH-terminal halfofCD37 has ahigh contentof polarand charged amino
acids and is concluded to be extracellularsince it contains all theN-linked glycosyla-
tion sites. Enzymatic deglycosylation studies have suggested that CD37 contains two
or three such structures (3), which is consistent with the threepossible N-linked sites
shown in theCD37 sequence (Fig. 2 B). Both CD37 and OX-44 migrate as extremely
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file for CD37 and CD20. The
algorithmofKyte andDoolittle
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heterogeneous bands in SDS-PAGE and this has been established to be due to N-linked
carbohydrate for CD37 (reference 3). The carbohydrate moieties of CD37 may be
unusually large since a maximum of three N-linked sites must account for -20 x
103 of the average apparent M, of 45 x 103 on SDS-PAGE. In the case of Thy-1,
three N-linked carbohydrate structures increase the apparent Mr of the protein by
ti 12 x 103 , as assessed by SDS-PAGE (8).
The structure of CD37 is unusual, and among lymphoid antigens, shows some
similarities only to the CD20 molecule of human B cells (11, 14). CD20 also lacks
a conventional NH2-terminal signal sequence, and as shown in Fig. 3, has three
hydrophobic segments which are more clearly defined by interrupting polar and
charged residues than those in CD37 (Fig. 3). However, it seems that the COOH-
terminal region of CD20 may be intracellular (14) and if so, the similarity between
CD37 and CD20 reduces to the likelihood that both molecules have multiple trans-
membrane sequences. There is no indication of an evolutionary relationship between
CD37 and CD20 as assessed by sequence similarity.
In the rat, CD37 (OX-44) is particularly interesting as a marker that allows the
identification ofan early cell in thymopoeisis (1, 2). An immediate question is whether
CD37 antibodies will be useful in identifying an equivalentcell in the human thymus.
Summary
Comparison of NH2-terminal protein sequence from the rat OX-44 antigen with
the sequence of the human CD37 antigen deduced from a cDNA clone shows that
these antigens are species homologues. The CD37 sequence is 244 amino acids in
length and lacks a conventional leader sequence. The molecule is likely to have an
NH2-terminal cytoplasmic domain followed by three transmembrane sequences that
lie within the first 110 amino acids. The rest of the molecule is hydrophillic and con-
tains three sites for N-linked glycosylation.
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